Report #2853487

Received Aug 11, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: AZ
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Cellulitis

Symptom narrative

cellulitis; This non-serious case was reported by a other health professional via sales rep and described the occurrence of cellulitis in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced cellulitis (Verbatim: cellulitis). The outcome of the cellulitis was unknown. The reporter considered the cellulitis to be related to Shingrix. The company considered the cellulitis to be related to Shingrix. Additional Information: GSK Receipt Date:29-JUL-2025 Medical assistant noted that patients reported cellulitis as an adverse reaction to their shingles vaccine. It was a subsequent dose.